Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells
BIOLOGICAL
2 trials
Sponsors
Shenzhen Beike Bio-Technology Co., Ltd.
Conditions
Autism
Burns
Phase 1
Safety and Efficacy of Stem Cell Therapy in Patients With Autism
Completed
NCT01343511
Shenzhen Beike Bio-Technology Co., Ltd.
Autism
Start: 2009-03-31
End: 2011-05-31
Updated: 2011-10-14
Allogenic Stem Cell Therapy in Patients With Acute Burn
NCT01443689
Shenzhen Beike Bio-Technology Co., Ltd.
Burns
Start: 2011-07-31
End: 2013-07-31
Target: 20
Updated: 2012-11-28
Related Papers
Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism
Journal of Translational Medicine
2013-08-27
168 citations